Table S1.
Patient demographics for CSF samples in relapsing-remitting multiple sclerosis patients in relapse or remission
| Sex | Age (y)* | Disease status | Therapy |
| M | 42 | Relapse | IFN-β |
| M | 29 | Relapse | IFN-β |
| M | 31 | Relapse | NA |
| M | 42 | Relapse | NA |
| M | 47 | Relapse | NA |
| M | 53 | Relapse | NA |
| F | 37 | Relapse | NA |
| M | 58 | Relapse | NA |
| M | 49 | Relapse | NA |
| M | 47 | Relapse | NA |
| M | 35 | Remission | Copolymer-1 |
| M | 32 | Remission | Copolymer-1 |
| M | 32 | Remission | NA |
| M | 39 | Remission | NA |
| F | 51 | Remission | Chlorambucil |
| F | 44 | Remission | Chlorambucil |
| F | 51 | Remission | Chlorambucil |
| M | 40 | Remission | Chlorambucil |
| M | 48 | Remission | Chlorambucil |
| M | 25 | Remission | Chlorambucil |
Information not available (NA).
*
Age did not differ between groups.